Insider Selling: Kewaunee Scientific (NASDAQ:KEQU) CFO Sells $128,280.00 in Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) CFO Donald Gardner III sold 3,000 shares of the firm’s stock in a transaction dated Thursday, October 9th. The shares were sold at an average price of $42.76, for a total value of $128,280.00. Following the transaction, the chief financial officer directly owned 11,564 shares in the company, valued at approximately $494,476.64. This represents a 20.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Kewaunee Scientific Stock Performance

Shares of NASDAQ KEQU opened at $41.53 on Monday. The stock has a market cap of $119.19 million, a price-to-earnings ratio of 10.06 and a beta of 0.68. The company has a current ratio of 2.32, a quick ratio of 1.63 and a debt-to-equity ratio of 0.88. Kewaunee Scientific Corporation has a 1-year low of $30.33 and a 1-year high of $71.33. The stock’s 50-day moving average is $50.32 and its 200 day moving average is $45.19.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings data on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. The company had revenue of $71.10 million for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.

Analyst Ratings Changes

Several equities analysts recently issued reports on KEQU shares. Wall Street Zen upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Weiss Ratings restated a “hold (c+)” rating on shares of Kewaunee Scientific in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.

Institutional Investors Weigh In On Kewaunee Scientific

A number of large investors have recently modified their holdings of the stock. Bank of America Corp DE raised its stake in Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares in the last quarter. IFP Advisors Inc lifted its holdings in Kewaunee Scientific by 61.5% in the first quarter. IFP Advisors Inc now owns 945 shares of the technology company’s stock worth $37,000 after buying an additional 360 shares during the period. Raymond James Financial Inc. purchased a new stake in Kewaunee Scientific in the second quarter worth about $60,000. Wedbush Securities Inc. purchased a new stake in Kewaunee Scientific in the second quarter worth about $232,000. Finally, Morgan Dempsey Capital Management LLC lifted its holdings in Kewaunee Scientific by 41.8% in the second quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company’s stock worth $247,000 after buying an additional 1,247 shares during the period. Institutional investors own 32.69% of the company’s stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.